Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YPEG-rhGH in pediatric short stature (PK/PD and safety/efficacy)
CTR20213288Phase 2Completed
- Sponsor
- Tebao Biotech
- Start
- Dec 2021
- Modality
- PEGylated Peptides → Modified Peptides → Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of inpegsomatropin in Idiopathic Short Stature (ISS), Small for gestational age (SGA), Turner syndrome (TS), sponsored by Tebao Biotech. Started Dec 2021; status: completed.
02
Drugs
inpegsomatropin
03
Conditions
Idiopathic Short Stature (ISS)Small for gestational age (SGA)Turner syndrome (TS)
Beyond the preview
Go deeper on CTR20213288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213288.